Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2688615018 | Oregovomab (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 2694114010 | Oregovomab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3650763016 | Product containing oregovomab (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3650764010 | Product containing oregovomab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3695230015 | Oregovomab product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3716012019 | Oregovomab-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Oregovomab-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Oregovomab-containing product | Is a | Monoclonal antibody antineoplastic agent | true | Inferred relationship | Some | ||
| Oregovomab-containing product | Is a | Monoclonal antibody-containing product | false | Inferred relationship | Some | ||
| Oregovomab-containing product | Is a | Antineoplastic agent | false | Inferred relationship | Some | ||
| Oregovomab-containing product | Has active ingredient | Oregovomab | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Oregovomab only product | Is a | True | Oregovomab-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR